A case of CA19-9 producing transitional cell carcinoma of the ureter

Acta Urologica Japonica

Volumn 49, Issue 9, 2003, Pages 543-545

  Yamamoto, Hironobu ^a   Ueda, Yasuo ^a   Maruyama, Takuo ^a   Kondou, Nobuyuki ^a   Nojima, Michio ^a   Takiuchi, Hidekazu ^a   Mori, Yoshinori ^a   Shima, Hiroki ^a   Kubota, Akira ^a  

^a NONE

Author keywords

Serum CA19 9; Ureteral tumor; Urothelial carcinoma

Indexed keywords

CA 19-9 ANTIGEN; TUMOR MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; MALE; NEPHROURETERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; RETROGRADE URETEROGRAPHY; TRANSITIONAL CELL CARCINOMA; URETER CARCINOMA; URETER DISEASE; UROGRAPHY;

CA-19-9 ANTIGEN; CARCINOMA, TRANSITIONAL CELL; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS;

EID: 0242458269     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Koprowski H, Steplewski Z, Mitchell K, et al.: Colorectal carcinoma antigen detected by hybrydoma antibodies. Somat Cell Mol Genet 5: 957-972, 1979
2. Atkinson AM, Samia AS, Medhat K, et al.: Gastrointestinal cancer associated antigen in immunoperoxidase assay. Cancer Res 42: 4820-4823, 1982
3. Oshio G, Ogawa K, Kudo H, et al.: Immunohistochemical distribution of CA19-9 in normal tissues of the kidney. Urol Int 45: 1, 1990
4. Abel PD, Cornell C, Buamah PK, et al.: Assessment of serum CA19-9 as a tumor marker in patients with carcinoma of the bladder and prostate. Br J Urol 59: 427-429, 1987